Indegene Ltd Company History

Raised funding from Nadathur Holdings & Investments Private Limited

Expanded operations to the USA by incorporating a subsidiary named Indegene, Inc.

Expanded operations to Southeast Asia by incorporating a subsidiary named Indegene Fareast Pte. Ltd. in Singapore

Acquisition of Medsn, Inc.1 a company in the USA which is engaged in medical education and marketing business, by one of our Material Subsidiaries, Indegene, Inc.2 through the merger of Medsn Merger Sub, Inc., an erstwhile wholly owned subsidiary of Indegene, Inc. with Medsn, Inc.

Expanded our services to include European territory

Received BS ISO/IEC 27001:2005 certification for information security management system3

Received ISO 9001:2000 certification for quality management system4

Expanded operations to China by incorporating a subsidiary named Indegene Lifesystems Consulting (Shanghai) Co., Ltd.

Acquisition of the Encima Group, Inc., a corporation which operates a digital service, marketing automation and analytics services business supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.

Acquisition of DT Associates Research and Consulting Services Limited, a consulting services company in UK supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.

Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences

Expanded operations to Japan by incorporating a subsidiary named Indegene Japan, LLC

Raised equity funding from CA Dawn Investments and Brighton Park Capital

Received BS ISO/IEC 27701:2019 certification for privacy information management system5

Acquisition of Medical Marketing Economics, LLC by one of our Material Subsidiaries, ILSL Holdings, Inc. and subsequent merger of Medical Marketing Economics, LLC with Indegene, Inc.

Expanded global operations with new offices in Mexico

Acquisition of Cult Health, a company engaged in the business of providing advertising services to parties in the healthcare sector, by one of our Material Subsidiaries, ILSL Holdings, Inc.

Expanded our presence in Europe with the acquisition of Indegene Healthcare Germany GmbH (formerly Sotus 852 GmbH) by our subsidiary, Indegene Ireland Limited

Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform

Acquisition of Trilogy Writing & Consulting GmbH, a company engaged in providing high-end medical writing to customers that include market-leading pharmaceutical companies, along with three of its wholly owned subsidiaries, by one of our Subsidiaries, Indegene Ireland Limited.

Ranked 167 in The Next 500 India’s Largest Emerging Companies by Fortune India